期刊文献+

蓝萼甲素纳米脂质体的制备、表征及对三阴性乳腺癌细胞的抑制作用 被引量:4

Preparation and characteristics of glaucocalyxin A-loaded nanoliposomes and its inhibition of triple negative breast cancer( TNBC)
原文传递
导出
摘要 目的:制备工艺稳定的蓝萼甲素纳米脂质体并考察其对细胞的抑制作用。方法:采用薄膜分散法制备蓝萼甲素纳米脂质体、马尔文粒径仪及透射电镜对其性质进行表征、超滤离心-高效液相色谱法进行包封率及载药量的测定,并考察蓝萼甲素纳米脂质体的体外释放行为;采用cck-8法考察蓝萼甲素纳米脂质体对sum149PT细胞系及sum149PT微球体的抑制作用,通过流式细胞仪确定sum149PT细胞的凋亡时期及凋亡比例。结果:优选处方及工艺制备的蓝萼甲素纳米脂质体粒径为(83.97±0.059)nm,Zeta电位为(-12.93±0.694)m V,包封率为(79.19±1.733)%,载药量为(3.43±0.250)%,且蓝萼甲素纳米脂质体具有较明显的缓释效果,并且对sum149PT细胞系及sum149PT微球体具有较好的抑制作用。结论:优选处方制得的蓝萼甲素纳米脂质体处方可行,制备工艺稳定,具有一定的抗三阴性乳腺癌效果。 Objective: To prepare glaucocalyxin A( GLA)-loaded nanoliposomes( GLA-LNs) with stable preparing technology and investigate its inhibitory effect on cells. Methods: The GLA-LNs was prepared with film dispersion method; the particle size,pd I,Zeta potential,and morphology were characterized by Malvern particle size analyzer and transmission electron microscope( TEM); the entrapment efficiency( EE) and drug loading( DL) of GLA-LNs were determined by HPLC method,and the release profile was studied; the cell cytotoxicity was measured with Kit CCK-8 method on sum149 PT cell line and sum149PT-TS; flow cytometry was used to determine the apoptosis effect on sum149 PT cell lines. Results: The particle size and the zeta potential of GLA-LNs were( 83. 97 ± 0. 059)nm and(-12. 93 ± 0. 694) m V; the results of morphology observation showed that GLA-LNs were round in shape and had uniform size; the EE and DL were( 79. 19 ± 1. 733) % and( 3. 43 ± 0. 250) %,respectively; GLA-LNs hadbetter sustained release effect and they were more stable; GLA-LNs showed better inhibitory effect on sum149 PT cell line and sum149PT-TS,and the apoptosis effect of GLA-LNs was better than GLA. Conclusion: The formulation and preparing process of GLA liposomes established in this study are feasible and reasonable; GLA-LNs have a better effect on triple negative breast cancer in vitro.
出处 《中国新药杂志》 CAS CSCD 北大核心 2016年第23期2724-2731,共8页 Chinese Journal of New Drugs
基金 国家自然科学基金资助项目(81172998)
关键词 蓝萼甲素 脂质体 sum149PT细胞 正交试验设计 glaucocalyxin A liposomes sum149PT cells orthogonal experimental design
  • 相关文献

参考文献2

二级参考文献18

  • 1朱会琴,逄涣欢,胡昌勤,冯芳.浊度法测定两性霉素B及其脂质体的效价[J].中国抗生素杂志,2005,30(12):752-755. 被引量:6
  • 2Clement V Sanchez P de Tribolet N Radovanovic I Ruiz i Altaba A.HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity[J].中国神经肿瘤杂志,2007,5(2):122-122. 被引量:96
  • 3Reya T,Morrison SJ ,Clarke MF,e( at. Stem cells,cancer,andcancer stem cells[J]. Nature,2001,414(6859) : 105-111.
  • 4Dean M.Fojo T.Bates S. Tumour stem cells and drug resist-ance[J]. Nat Rev Cancer,2005,5(4) : 275-284.
  • 5Gupta PB’Onder TT,Jiang G,et al. Identification of selectiveinhibitors of cancer stem cells by high-throughput screening[J]. Cell,2009,138C4):645-659.
  • 6Naujokat C,Steinhart R. Salinomycin as a drug for targeting hu-man cancer stem cells[J]. Biomed Res Int,2012,2012:1-17.
  • 7Huczynski A. Salinomycin: a new cancer drug candidate[J].Chem Biol Drug Des, 2012 ,79(3) : 235-238.
  • 8Liu Y, Miyoshi H, Nakamura M. Nanomedicine for drag de-livery and imaging:a promising avenue for cancer therapy anddiagnosis using targeted functional nanoparticles [ J]. Int JCancer,2007,120(12):2527-2537.
  • 9Chang H,Yeh M. Clinical development of liposome-baseddrugs: formulation, characterization, and therapeutic efficacy[J]. Int J Nanomed,2012,7 : 49-60.
  • 10Barenholz YC. Doxil -the first FDA-approved nano-drug: les-sons learned[J], J Control Release, 2012 ,160(2) : 117-134.

共引文献34

同被引文献48

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部